Fortis Malar Hospitals last traded at ₹40.80 (2026-10-13). Over the past month the stock moved -10.3%, three months the stock moved -26.2%, year the stock moved -37.2%. Its closing range over 52 weeks is ₹39.98 – ₹68.62, with the latest close 40.5% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of setting up, managing, and operating a multi-speciality hospital.[1]
Business Overview:[1] FMHL is a subsidiary of Fortis Hospitals Limited. The company used to run a multi-speciality hospital facility in Chennai. The hospital building was owned by a fellow subsidiary, Fortis Health Management Limited. The Parent Company has 1 wholly owned subsidiary company, Malar Stars Medicare Limited
In the latest quarter (Jun 2026), Fortis Malar Hospitals reported sales of ₹0.00 crore (-100.0%) and net profit of ₹0.15 crore (-96.4%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.00 | -0.33 | – | 0.15 | 0.08 |
| Mar 2026 | 0.00 | -0.55 | – | -0.05 | -0.03 |
| Dec 2025 | 0.00 | -0.33 | – | 0.02 | 0.01 |
| Sep 2025 | 0.03 | -0.38 | -1,266.67 | 0.01 | 0.01 |
| Jun 2025 | 0.02 | -0.33 | -1,650.00 | 4.15 | 2.21 |
| Mar 2025 | 0.00 | -0.37 | – | 0.36 | 0.19 |
| Dec 2024 | 0.00 | -0.41 | – | 0.01 | 0.01 |
| Sep 2024 | 0.00 | -0.47 | – | 0.09 | 0.05 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -100.0% | -100.0% | -100.0% | – | – | – | – | -100.0% |
| Operating profit growth | – | – | -177.1% | – | – | – | – | – |
| Net profit growth | – | – | -99.3% | – | -88.9% | +100.0% | -113.9% | -96.4% |
| EPS growth | – | – | -99.3% | – | -80.0% | +0.0% | -115.8% | -96.4% |
| OPM % | – | – | – | -1650.0% | -1266.7% | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Fortis Malar Hospitals reported sales of ₹0.05 crore and net profit of ₹4.14 crore (+961.5%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.05 | -1.57 | -3,140.00 | 4.14 | 2.21 |
| Mar 2025 | 0.00 | -2.14 | – | 0.39 | 0.21 |
| Mar 2024 | 59.01 | -1.21 | -2.05 | 45.32 | 24.18 |
| Mar 2023 | 85.95 | 4.57 | 5.32 | -15.48 | -8.26 |
| Mar 2022 | 86.18 | 3.44 | 3.99 | -8.27 | -4.41 |
| Mar 2021 | 69.24 | -6.34 | -9.16 | -7.87 | -4.20 |
| Mar 2020 | 111.87 | -2.70 | -2.41 | -8.89 | -4.74 |
| Mar 2019 | 144.59 | -2.35 | -1.63 | 2.06 | 1.10 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -3.1% | -22.6% | -38.1% | +24.5% | -0.3% | -31.3% | -100.0% | – |
| Operating profit growth | -234.3% | – | – | – | +32.8% | -126.5% | – | – |
| Net profit growth | -38.0% | -531.6% | – | – | – | – | -99.1% | +961.5% |
| EPS growth | -38.2% | -530.9% | – | – | – | – | -99.1% | +952.4% |
| OPM % | -1.6% | -2.4% | -9.2% | 4.0% | 5.3% | -2.1% | – | -3140.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Fortis Malar Hospitals.
Get Free AI Stock Analysis FREE →No recent news available for Fortis Malar Hospitals.
Fortis Malar Hospitals shares were last quoted at ₹40.80 (+1.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Fortis Malar Hospitals has a price-to-earnings (P/E) ratio of 590.29 and a price-to-book (P/B) ratio of 2.25. The industry P/E is 101.02.
The 52-week high of Fortis Malar Hospitals is ₹76.00 and the 52-week low is ₹40.00.
The market capitalisation of Fortis Malar Hospitals is about ₹77.44 crore.
In the latest quarter (Jun 2026), Fortis Malar Hospitals reported sales of ₹0.00 crore (-100.0%) and net profit of ₹0.15 crore (-96.4%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Fortis Malar Hospitals has a 3-year ROE of -2.00%, 3-year profit growth of 31.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 62.71% of Fortis Malar Hospitals.
Fortis Malar Hospitals belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z